Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CNOT9 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
mRNA | C1QTNF5 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | NOL4 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
mRNA | KLK8 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
mRNA | TAF3 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
mRNA | PTPRK | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | RNASE10 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | FXYD7 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | DPYSL2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
mRNA | ABT1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |